Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
5.76
+0.23 (4.16%)
At close: Sep 2, 2025, 4:00 PM
5.73
-0.03 (-0.52%)
After-hours: Sep 2, 2025, 4:00 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $326.31 million as of September 2, 2025. Its market cap has increased by 36.57% in one year.
Market Cap
326.31M
Enterprise Value
111.98M
1-Year Change
36.57%
Ranking
Category
Stock Price
$5.76
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $326.31M, a decrease of -85.21%. That is a compound annual growth rate of -35.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 314.92M | -9.86% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |